Misplaced Pages

2,5-Dimethoxy-4-amylamphetamine

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from DOAM)
2,5-Dimethoxy-4-amylamphetamine
DOAM molecule
Names
Preferred IUPAC name 1-(2,5-Dimethoxy-4-pentylphenyl)propan-2-amine
Other names DOAM;
2,5-Dimethoxy-4-amyl-amphetamine;
2,5-Dimethoxy-4-amyl-1-ethyl-(alpha-methyl)amine
Identifiers
CAS Number
3D model (JSmol)
Abbreviations DOAM
ChEMBL
ChemSpider
PubChem CID
UNII
CompTox Dashboard (EPA)
InChI
  • InChI=1S/C16H27NO2/c1-5-6-7-8-13-10-16(19-4)14(9-12(2)17)11-15(13)18-3/h10-12H,5-9,17H2,1-4H3Key: VLJORLCVOAUUKM-UHFFFAOYSA-N
  • InChI=1/C16H27NO2/c1-5-6-7-8-13-10-16(19-4)14(9-12(2)17)11-15(13)18-3/h10-12H,5-9,17H2,1-4H3Key: VLJORLCVOAUUKM-UHFFFAOYAN
SMILES
  • CCCCCC1=CC(OC)=C(CC(C)N)C=C1OC
  • COc1cc(CCCCC)c(cc1CC(C)N)OC
Properties
Chemical formula C16H27NO2
Molar mass 265.39 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). ☒N verify (what is  ?) Infobox references
Chemical compound

Dimethoxy-4-amylamphetamine (DOAM) is a lesser-known psychedelic drug and a substituted amphetamine. DOAM was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 10 mg, and the duration is unknown. DOAM produces a bare threshold and tenseness. As the 4-alkyl chain length is increased from shorter homologues such as DOM, DOET and DOPR which are all potent hallucinogens, the 5-HT2 binding affinity increases, rising to a maximum with the 4-(n-hexyl) derivative before falling again with even longer chains, but compounds with chain length longer than n-propyl, or with other bulky groups such as isopropyl, t-butyl or γ-phenylpropyl at the 4- position, fail to substitute for hallucinogens in animals or produce hallucinogenic effects in humans, suggesting these have low efficacy and are thus antagonists or partial agonists at the 5-HT2A receptor.

See also

References

  1. Shulgin AT, Dyer DC (December 1975). "Psychotomimetic phenylisopropylamines. 5. 4-Alkyl-2,5-dimethoxyphenylisopropylamines". Journal of Medicinal Chemistry. 18 (12): 1201–4. doi:10.1021/jm00246a006. PMID 1195275.
  2. Seggel MR, Yousif MY, Lyon RA, Titeler M, Roth BL, Suba EA, Glennon RA (March 1990). "A structure-affinity study of the binding of 4-substituted analogues of 1-(2,5-dimethoxyphenyl)-2-aminopropane at 5-HT2 serotonin receptors". Journal of Medicinal Chemistry. 33 (3): 1032–6. doi:10.1021/jm00165a023. PMID 2308135.
  3. Dowd CS, Herrick-Davis K, Egan C, DuPre A, Smith C, Teitler M, Glennon RA (August 2000). "1--2-aminopropanes as 5-HT(2A) partial agonists". Journal of Medicinal Chemistry. 43 (16): 3074–84. doi:10.1021/jm9906062. PMID 10956215.
  4. Kruegel AC. Phenalkylamines and Methods of Making and Using the Same. Patent WO 2022/192781

External links


Stub icon

This psychoactive drug-related article is a stub. You can help Misplaced Pages by expanding it.

Categories:
2,5-Dimethoxy-4-amylamphetamine Add topic